This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Thomas Rauch: Innovator in Pharmaceutical Compositions
Introduction
Thomas Rauch is a notable inventor based in Ehingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic disorders. His innovative work has led to the development of a unique pharmaceutical composition aimed at addressing critical health issues.
Latest Patents
Thomas Rauch holds a patent for "Pharmaceutical combinations for the treatment of metabolic disorders." This invention relates to a pharmaceutical composition that includes specific therapeutic agents suitable for treating or preventing conditions such as type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance, and hyperglycemia. The patent outlines methods for preventing or treating metabolic disorders and related conditions, showcasing his commitment to advancing medical science.
Career Highlights
Rauch is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to leverage his expertise in developing innovative solutions for complex health challenges. His work is instrumental in enhancing the quality of life for individuals affected by metabolic disorders.
Collaborations
Throughout his career, Thomas has collaborated with talented professionals, including Bradford S. Hamilton and Manami Tsutsumi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Thomas Rauch's contributions to pharmaceutical innovations demonstrate his dedication to improving health outcomes for individuals with metabolic disorders. His patent and work at Boehringer Ingelheim International GmbH highlight his role as a key player in the field of medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
